acrylamide has been researched along with Wallerian Degeneration in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farah, MH; Ferraris, D; Griffin, JW; Hoffman, PN; Nguyen, T; Pan, BH; Price, DL; Slusher, BS; Tsukamoto, T; Wong, PC | 1 |
| Man-Fu, H; Murai, Y; Ohnishi, A; Qiu-Yue, H; Yamamoto, T | 1 |
| Griffin, JW; Li, CY; Stoll, G; Trapp, BD | 1 |
| Kaji, R; Sumner, AJ; Suzumura, A | 1 |
4 other study(ies) available for acrylamide and Wallerian Degeneration
| Article | Year |
|---|---|
Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system.
Topics: Acrylamide; Amyloid Precursor Protein Secretases; Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid Endopeptidases; Axons; Biotin; Enzyme Inhibitors; Ganglia, Spinal; Immunohistochemistry; Infusion Pumps, Implantable; Mice; Mice, 129 Strain; Mice, Knockout; Microscopy, Electron; Myelin Sheath; Nerve Degeneration; Nerve Regeneration; Neuromuscular Junction; Paclitaxel; Peripheral Nervous System; Phagocytosis; Sciatic Nerve; Wallerian Degeneration | 2011 |
Differential effects of acrylamide on the degeneration and regeneration of myelinated fibers between C57BL/Ola and C57BL/6J mice after crush injury.
Topics: Acrylamide; Acrylamides; Animals; Humans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nerve Degeneration; Nerve Fibers, Myelinated; Nerve Regeneration; Neurotoxins; Sciatic Nerve; Wallerian Degeneration | 1997 |
Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation.
Topics: Acrylamide; Acrylamides; Animals; Antigens; Immunohistochemistry; Macrophages; Male; Microscopy, Electron; Myelin Sheath; Nerve Degeneration; Peripheral Nerves; Phagocytes; Rats; Rats, Inbred Lew; Schwann Cells; Wallerian Degeneration | 1989 |
Physiological consequences of antiserum-mediated experimental demyelination in CNS.
Topics: Acrylamide; Acrylamides; Animals; Central Nervous System Diseases; Demyelinating Diseases; Evoked Potentials, Somatosensory; Galactosylceramides; Immune Sera; Injections; Neural Conduction; Rats; Reaction Time; Time Factors; Wallerian Degeneration | 1988 |